The acquisition extends ACT’s cannabis testing services into Florida; the company already tests cannabis in Illinois, Ohio, Michigan, Pennsylvania, and New York.
In the observational study, the researchers found that patients’ ratings of average pain severity, worst pain severity, and pain interference all fell after starting medical cannabis treatment.
The study observed the health records of 6.9 million people in Denmark, making it one of the most comprehensive observational studies of its kind ever undertaken.
The report, published in the journal Drug Science, Policy and Law, details the experiences of a 35-year-old man who had been diagnosed with a mild case of red-green color blindness five years earlier.
After two weeks of cannabis use, the patients reported significant improvements in their sleep and cognition as well as reductions in their levels of pain.
The acquisition extends Smithers’ cannabis testing services into Arizona; the company already tests cannabis in Illinois, Massachusetts, and New York.
Over a thousand licensed companies have left Maine’s medical cannabis market in the past two years, according to a new report from the state regulator.